| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
immunoglobulin like domain containing receptor 1 | 0.729 | 0.346 | 2.6E-12 |
|
disease | 0.340 | definitive | 1.000 | 8 | 0 | 2005 | 2018 | ||||||||
|
myosin VI | 0.631 | 0.731 | 2.4E-05 |
|
disease | 0.360 | definitive | 1.000 | 7 | 0 | 2001 | 2019 | ||||||||
|
MARVEL domain containing 2 | 0.705 | 0.462 | 1.3E-12 |
|
disease | 0.340 | definitive | 1.000 | 7 | 0 | 2005 | 2016 | ||||||||
|
transmembrane inner ear | 0.890 | 0.115 | 7.7E-05 |
|
disease | 0.320 | definitive | 1.000 | 7 | 0 | 2002 | 2014 | ||||||||
|
tight junction protein 2 | 0.663 | 0.500 | 3.2E-11 |
|
disease | 0.310 | limited | 1.000 | 6 | 0 | 2008 | 2015 | ||||||||
|
small muscle protein X-linked | 0.682 | 0.500 | 0.62 |
|
disease | 0.320 | definitive | 1.000 | 6 | 0 | 2011 | 2020 | ||||||||
|
glutaredoxin and cysteine rich domain containing 1 | 0.861 | 0.115 | 3.9E-11 |
|
disease | 0.330 | definitive | 1.000 | 6 | 0 | 2004 | 2016 | ||||||||
|
whirlin | 0.670 | 0.385 | 7.7E-05 |
|
disease | 0.320 | moderate | 1.000 | 6 | 0 | 2003 | 2017 | ||||||||
|
estrogen related receptor beta | 0.565 | 0.846 | 0.13 |
|
disease | 0.310 | definitive | 1.000 | 6 | 0 | 2007 | 2014 | ||||||||
|
otogelin | 0.805 | 0.231 | 6.6E-37 |
|
disease | 0.300 | definitive | 1.000 | 6 | 0 | 1997 | 2017 | ||||||||
|
cadherin related 23 | 0.539 | 0.769 | 3.2E-06 |
|
disease | 0.390 | definitive | 1.000 | 6 | 0 | 2001 | 2019 | ||||||||
|
collagen type XI alpha 2 chain | 0.435 | 0.846 | 0.70 |
|
disease | 0.400 | moderate | 1.000 | 6 | 0 | 1999 | 2015 | ||||||||
|
taperin | 0.839 | 0.115 | 7.2E-03 |
|
disease | 0.340 | definitive | 1.000 | 6 | 0 | 2010 | 2019 | ||||||||
|
USH1 protein network component harmonin | 0.628 | 0.538 | 4.0E-18 |
|
disease | 0.340 | limited | 1.000 | 5 | 0 | 2000 | 2009 | ||||||||
|
calcium binding protein 2 | 0.861 | 0.115 | 2.5E-03 |
|
disease | 0.310 | strong | 1.000 | 5 | 0 | 2007 | 2019 | ||||||||
|
myosin IIIA | 0.780 | 0.269 | 1.8E-45 |
|
disease | 0.310 | strong | 1.000 | 5 | 0 | 2002 | 2018 | ||||||||
|
otogelin like | 0.805 | 0.269 | 4.7E-52 |
|
disease | 0.310 | definitive | 1.000 | 5 | 0 | 2012 | 2017 | ||||||||
|
CEA cell adhesion molecule 16, tectorial membrane component | 0.805 | 0.192 | 1.6E-05 |
|
disease | 0.320 | moderate | 1.000 | 4 | 0 | 2011 | 2015 | ||||||||
|
stereocilin | 0.700 | 0.192 | 1.8E-15 |
|
disease | 0.320 | definitive | 1.000 | 4 | 0 | 2001 | 2019 | ||||||||
|
purinergic receptor P2X 2 | 0.585 | 0.769 | 9.7E-13 |
|
disease | 0.320 | moderate | 1.000 | 4 | 0 | 2008 | 2017 | ||||||||
|
grainyhead like transcription factor 2 | 0.590 | 0.731 | 1.00 |
|
disease | 0.300 | strong | 1.000 | 4 | 0 | 2002 | 2016 | ||||||||
|
myosin IF | 0.722 | 0.385 | 2.4E-07 |
|
disease | 0.300 | disputed | 1.000 | 3 | 0 | 2002 | 2012 | ||||||||
|
lysyl-tRNA synthetase 1 | 0.636 | 0.577 | 4.2E-09 |
|
disease | 0.320 | limited | 1.000 | 3 | 0 | 2004 | 2019 | ||||||||
|
tenascin C | 0.433 | 0.846 | 1.3E-07 |
|
disease | 0.310 | limited | 1.000 | 3 | 0 | 1999 | 2013 | ||||||||
|
glutaredoxin and cysteine rich domain containing 2 | 0.861 | 0.115 | 1.0E-07 |
|
disease | 0.300 | moderate | 1.000 | 3 | 0 | 2014 | 2018 |